About the Radiotherapy Board

Coronavirus (COVID-19)

The Radiotherapy Board recognises the significant challenges that have been faced by radiotherapy professionals in seeking to deliver safe, high-quality treatment and care for patients during the COVID-19 pandemic. It applauds the way in which the radiotherapy community has worked together at this very difficult time, to keep services running while ensuring the safety of both patients and staff.

With a move towards a recovery and restoration phase for radiotherapy services - and the fresh challenges that this presents - the  Board continues to commend the advice, support and guidance issued by its constituent partner bodies – the Institute of Physics and Engineering in MedicineThe Royal College of Radiologists and the Society and College of Radiographers – as well as the advice provided nationally (which is available through onward links on all three professional body websites).

The Radiotherapy Board provides guidance, oversight and support for the continuing development of high-quality radiotherapy services for cancer patients in the UK.

Established in 2013 by The Royal College of Radiologists (RCR), the Society and College of Radiographers (SCoR), and the Institute of Physics and Engineering in Medicine (IPEM), it has representation from across the four UK nations and from other organisations closely involved in radiotherapy services.

The Board’s priorities are:

  • Workforce – advising stakeholders and policy-makers about future workforce requirements, to ensure a trained, skilled and flexible, multi-disciplinary radiotherapy workforce
  • Guidance – providing professional guidance to underpin the highest professional standards of radiotherapy service delivery
  • Equipment – promoting the need for sufficient radiotherapy equipment to meet increasing patient demand and provide a high-quality service.

The Board's current work programme includes:

  • Guidance on the accuracy of radiotherapy treatment delivery
  • Supporting the ongoing development of the Radiotherapy Dataset
  • Guidance on radiation exposure related to treatment verification
  • Close collaboration with the Clinical and Translational Radiotherapy Research Working Group to maximise clinical trial participation.

Further information about the Radiotherapy Board is available in this interview with the Board's 2017/18 Chair, Mr John Burton.

Meeting dates for 2020:

  • Thursday 18 June
  • Thursday 5 November

For enquiries about the Radiotherapy Board, please write to the Chair via the Radiotherapy Board Secretariat at The Royal College of Radiologists.